The Discovery of Transcutaneous Spinal Electroanalgesia and Its Relief of Chronic Pain

Macdonald, Alexander; Coates, Tim W

doi:10.1016/s0031-9406(05)66616-3

Cited by 23 publications

(20 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Robb et al [70] conducted a randomized sham-controlled crossover trial of TENS and transcutaneous spinal electroanalgesia (TSE), which is a TENS-like device which delivers currents that do not produce any appreciable electrical paresthesia. TSE is claimed to reduce central sensitization, although evidence has not been forthcoming [71]. Forty five women with chronic pain associated with breast cancer treatment administered each intervention at home for a 3-week period followed by a 1-week washout.…”

Section: Tens For Cancer-related Painmentioning

confidence: 99%

Transcutaneous Electrical Nerve Stimulation and Acupuncture

Johnson

2010

Evidence‐Based Chronic Pain Management

View full text Add to dashboard Cite

Section: Tens For Cancer-related Painmentioning

confidence: 99%

Transcutaneous Electrical Nerve Stimulation and Acupuncture

Johnson

2010

Evidence‐Based Chronic Pain Management

View full text Add to dashboard Cite

“…171 Preliminary data suggest that TSE may help to reduce general practitioner consultation rates and that patients are satis ed with its effects. 172,173 TSE delivers pulsed currents with a high frequency (600-10,00 pps), high voltage and short pulse duration (1.5-4 µs) via two pad electrodes positioned either at T1 and T12 or straddling C3-C5.…”

Section: Transcutaneous Spinal Electroanalgesiamentioning

confidence: 99%

“…The intention of TSE is to activate excitable tissue in the spinal cord in order to reduce central sensitization by 'resetting' central nervous system neuronal activity back to its presensitized state. 171 Physiological studies suggest that conventional TENS may reduce central sensitization, [174][175][176][177] although there have so far been no experiments investigating the effects of TSE. If proved, TSE could be useful in the management of hyperalgesia and allodynia.…”

Section: Transcutaneous Spinal Electroanalgesiamentioning

confidence: 99%

“…It is also claimed that, because peripheral nerve input converges at the spinal cord, TSE effects will be widespread over the body. 171 Studies on the effects of TSE are sparse. The initial promise of TSE was based on observations that it reduced pain by 60% in over two-thirds of a sample of 100 pain patients.…”

Section: Transcutaneous Spinal Electroanalgesiamentioning

confidence: 99%

“…The initial promise of TSE was based on observations that it reduced pain by 60% in over two-thirds of a sample of 100 pain patients. 171 A preliminary RCT on eight patients suffering musculoskeletal pain found that TSE produced signi cantly greater reductions in pain measures than TENS. Each patient received one 20-minute treatment of TSE (10 kHz, 1.5 µs) and one 20-minute treatment of TENS (100 pps, 200 µs) in a randomized, double-blind crossover fashion.…”

Section: Transcutaneous Spinal Electroanalgesiamentioning

confidence: 99%

See 2 more Smart Citations

Transcutaneous Electrical Nerve Stimulation (TENS) and TENS-like devices: do they provide pain relief?

Johnson¹

2001

Pain Reviews

View full text Add to dashboard Cite

The term 'transcutaneous electrical nerve stimulation' (TENS) is synonymous with a standard TENS device. Increasingly, nonstandard TENS-like devices are being marketed to health care professionals for pain relief. These include: interferential current therapy, microcurrent electrical therapy, high-voltage pulsed (galvanic) currents, TENS-pens, transcranial electrical stimulation and Limoge currents, Codetron, transcutaneous spinal electroanalgesia, action potential simulation, and H-wave therapy. This review evaluates the effectiveness of TENS and TENS-like devices for pain relief, to inform health care professionals about device selection. The results from systematic reviews suggest that TENS is not effective for postoperative pain and labour pain, although volatile evaluation models may partly explain the ndings. Evidence is inconclusive for chronic pain. Health care professionals should not dismiss the use of TENS for any condition until the issues in clinical trial design and review methodology have been resolved. There is limited experimental evidence available for most TENS-like devices. Claims by manufacturers about the speci city and extent of effects produced using TENS-like devices are overstated and could probably be achieved by using a standard TENS device or a microcurrent electrical therapy device. When making decisions about device selection, health care professionals should consider the physiological intention of currents and whether this can be achieved by using particular devices. Clinical trials that examine the relative effectiveness of TENS-like devices with a standard TENS device are desperately needed.

show abstract